T. Rowe Price Associates
OXFD

T. Rowe Price Associates’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

T. Rowe Price Associates’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-858,201
Closed -$12M – 2603
2017
Q4 		$12M Buy
858,201
+109,574
+15% +$1.61M ﹤0.01% 1306
2017
Q3 		$12.6M Sell
748,627
-25,400
-3% -$413K ﹤0.01% 1301
2017
Q2 		$13M Sell
774,027
-12,100
-2% -$181K ﹤0.01% 1271
2017
Q1 		$12.2M Sell
786,127
-24,200
-3% -$346K ﹤0.01% 1292
2016
Q4 		$12.1M Sell
810,327
-2,600
-0.3% -$36.5K ﹤0.01% 1276
2016
Q3 		$10.2M Sell
812,927
-288
-0% -$2.89K ﹤0.01% 1310
2016
Q2 		$7.32M Sell
813,215
-8,231
-1% -$80.6K ﹤0.01% 1342
2016
Q1 		$8.14M Sell
821,446
-1,100
-0.1% -$11.3K ﹤0.01% 1316
2015
Q4 		$9.46M Sell
822,546
-6,700
-0.8% -$82.9K ﹤0.01% 1298
2015
Q3 		$11.2M Sell
829,246
-30,654
-4% -$416K ﹤0.01% 1286
2015
Q2 		$11.9M Buy
859,900
+1,400
+0.2% +$18.9K ﹤0.01% 1304
2015
Q1 		$12.1M Buy
858,500
+8,600
+1% +$117K ﹤0.01% 1287
2014
Q4 		$11.6M Hold
849,900
– – ﹤0.01% 1280
2014
Q3 		$13M Sell
849,900
-900
-0.1% -$13.8K ﹤0.01% 1238
2014
Q2 		$14.3M Sell
850,800
-4,500
-0.5% -$81K ﹤0.01% 1223
2014
Q1 		$17.2M Buy
855,300
+1,400
+0.2% +$30.3K ﹤0.01% 1153
2013
Q4 		$16.5M Buy
+853,900
New +$15.1M ﹤0.01% 1146

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Associates's OXFD Position: Q1 2018 in Review

T. Rowe Price Associates sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 858,201 shares — an estimated $12M sold.

T. Rowe Price Associates first reported a position in OXFD in Q4 2013 and held it in 17 quarters. The position peaked at $17.2M in Q1 2014. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

  • T. Rowe Price Associates reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 858,201 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $12M.
  • T. Rowe Price Associates first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 17 quarters.
  • T. Rowe Price Associates's Oxford Immunotec Global PLC Ordinary Shares position peaked at $17.2M in Q1 2014.
  • 74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.